Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL37858

O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F.[In+3]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 1/20 0.44
CA13 Q8N1Q1 1/20 0.44
GPR3 P46089 2/20 0.42
ACHE P22303 2/20 0.33
KCNH2 Q12809 7/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31
F2 P00734 1/20 0.30
PRSS1 P07477 1/20 0.30
PRSS2 P07478 1/20 0.30
PRSS3 P35030 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL31137715 0.93 GPR3 (0.39) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25292878 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL2140292 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL4367100 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25285896 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25255863 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL23430060 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25287606 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL20570425 0.92
Trifluoromethanesulfonic Acid SCHEMBL25301943 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1675 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122051359-A Polymer electrolyte and contain this sodium ion battery of polymer electrolyte 浙江钠创新能源有限公司 2026-05-15 CN claimed
CN-122036589-A Method for synthesizing isopentenyl substituted indolone through oxygen mediation 中国科学院大连化学物理研究所 2026-05-15 CN claimed
CN-122010956-A Chiral 1, 4-diazabicyclo [3.1.1] heptane derivatives, synthesis and application thereof 浙江师范大学 2026-05-12 CN claimed
US-20250353825-A1 CANNABICYCLOL DERIVATIVES AND PREPARATION METHODS THEREOF KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2025-11-20 US claimed
EP-4646506-A1 SHAPE-CONTROLLED SYNTHESIS OF III-V COLLOIDAL NANOCRYSTALS Quantum Science Ltd (GB) 2025-11-12 EP claimed
EP-4626954-A2 RING OPENING POLYMERIZATION OF CYCLIC SILOXANES CHT USA INC. (US) 2025-10-08 EP claimed
US-12435033-B2 Method and device for preparing adiponitrile ZHEJIANG NHU COMPANY LTD (CN) 2025-10-07 US claimed
US-20250289842-A1 Processes for Making NAG-25, a Carbohydrate Targeting Moiety, and its Intermediates AMGEN INC. 2025-09-18 US claimed
CN-120192289-A Synthesis method of multi-functional 2-alkenyl furan-ring-4-ketone and 5-alkenyl-3-furan carbonyl compound 首都医科大学 2025-06-24 CN claimed
CN-120137618-A Organosilicon emulsifier for oil-in-water drilling fluid and preparation method thereof 中国石油集团川庆钻探工程有限公司 2025-06-13 CN claimed
WO-2005121115-A1 PROCESS FOR THE MANUFACTURE OF CHROMAN DERIVATIVES, ESPECIALLY α-TOCOPHEROL AND ALKANOATES THEREOF DSM IP ASSETS B.V. (NL) 2005-12-22 WO claimed
US-20050277777-A1 Process for the manufacture of chroman derivatives, especially alpha-tocopherol and alkanoates thereof BONRATH WERNER 2005-12-15 US claimed
CN-1680319-A a-methyl-beta,-beta-double indolene compound, synthesis and use thereof SHANGHAI ORGANIC CHEMICAL INST (CN) 2005-10-12 CN claimed
CN-1680320-A Beta, beta-double indolene compound, synthesis and use thereof SHANGHAI ORGANIC CHEMICAL INST (CN) 2005-10-12 CN claimed
US-20050171362-A1 Process for the manufacture of alkenylated hydroxylated aromatic compounds, of chroman compounds and of their acylated derivatives DSM IP ASSETS B.V. (NL) 2005-08-04 US claimed
WO-2005054223-A2 PROCESS FOR THE MANUFACTURE OF ALKENYLATED HYDROXYLATED AROMATIC COMPOUNDS, OF CHROMAN COMPOUNDS AND OF THEIR ACYLATED DERIVATIVES DSM IP ASSETS B.V. (NL) 2005-06-16 WO claimed
US-20040122251-A1 Process of synthesis of compounds having nitrile functions from ethylenically unsaturated compounds RHODIA POLYAMIDE INTERMEDIATES (FR) 2004-06-24 US claimed
WO-2004031134-A1 PROCESS FOR MAKING SUBSTITUTED ARYL SULFONAMIDES USING AN INDIUM BASED CATALYST SYSTEM SYNGENTA LIMITED (GB) 2004-04-15 WO claimed
US-20040063956-A1 Hydrocyanation method for ethylenically unsaturated organic compounds INVISTA NORTH AMERICA SARL 2004-04-01 US claimed
US-20040063991-A1 Method for making nitrile compounds from ethylenically unsaturated compounds INVISTA NORTH AMERICA SARL 2004-04-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277777-A1 Process for the manufacture of chroman derivatives, especially alpha-tocopherol and alkanoates thereof TTPA, TCP1, TST CA1 1354/4885CA2 1219/4885CA7 1776/4885
US-20250289842-A1 Processes for Making NAG-25, a Carbohydrate Targeting Moiety, and its Intermediates ENGASE, MAN2B2, GALNT2 CA1 349/4885CA2 2017/4885CA7 407/4885
US-20050171362-A1 Process for the manufacture of alkenylated hydroxylated aromatic compounds, of chroman compounds and of their acylated derivatives TTPA, AADAC, TCP1 CA1 3256/4885CA2 1662/4885CA7 1857/4885
US-12435033-B2 Method and device for preparing adiponitrile ADIPOR2, ADIPOR1, ALKBH1 CA1 4379/4885CA2 3487/4885CA7 1692/4885
US-20040063956-A1 Hydrocyanation method for ethylenically unsaturated organic compounds ALKBH3, HPD, ALKBH1 CA1 3857/4885CA2 2559/4885CA7 2206/4885
US-20250353825-A1 CANNABICYCLOL DERIVATIVES AND PREPARATION METHODS THEREOF CNR2, HMOX1, CASP6 CA1 3559/4885CA2 4032/4885CA7 3193/4885
US-20040122251-A1 Process of synthesis of compounds having nitrile functions from ethylenically unsaturated compounds DBN1, NCSTN, NOS2 CA1 347/4885CA2 2210/4885CA7 3473/4885
US-20040063991-A1 Method for making nitrile compounds from ethylenically unsaturated compounds ALOX5, FABP4, FASN CA1 3712/4885CA2 2814/4885CA7 2208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.